We have previously demonstrated that transcriptionally active high-risk HPV (hr-HPV) is strongly incriminated in Barrett's dysplasia (BD) and oesophageal adenocarcinoma (OAC) using mainly fresh frozen tissue. This study aimed to identify biomarkers of active HPV infection in Barrett's metaplasia, (BM)/BD/OAC by immunohistochemical staining (IHC) of formalin-fixed paraffin embedded (FFPE) tissue for aberrations of p53 and the retinoblastoma (pRb) pathway, which are targets for the viral oncoproteins, E6/E7, respectively. Prospectively, BM (n 5 81)/BD (n 5 72)/OAC (n 5 65) FFPE specimens were subjected to IHC staining for pRb, p16
We have previously demonstrated that transcriptionally active high-risk HPV (hr-HPV) is strongly incriminated in Barrett's dysplasia (BD) and oesophageal adenocarcinoma (OAC) using mainly fresh frozen tissue. This study aimed to identify biomarkers of active HPV infection in Barrett's metaplasia, (BM)/BD/OAC by immunohistochemical staining (IHC) of formalin-fixed paraffin embedded (FFPE) tissue for aberrations of p53 and the retinoblastoma (pRb) pathway, which are targets for the viral oncoproteins, E6/E7, respectively. Prospectively, BM (n 5 81)/BD (n 5 72)/OAC (n 5 65) FFPE specimens were subjected to IHC staining for pRb, p16 INK4A , cyclin D 1 , p53 and RNA in-situ hybridization for E6/E7 transcripts. HPV DNA was determined via PCR in fresh frozen specimens. Viral load measurement (real-time PCR) and Next Generation Sequencing of TP53 was performed. Of 218 patients, 56 were HPV DNA positive [HPV16 (n 5 42), 18 (n 5 13), 6 (n 5 1)]. Viral load was low. Transcriptionally active HPV (DNA We have previously hypothesized and proven that transcriptionally active high-risk HPV (hr-H PV) is strongly associated with Barrett's dysplasia (BD) and oesophageal adenocarcinoma (OAC). 1, 2 Both increasing hr-HPV viral load and inte-driven cancers. [5] [6] [7] Recently, we discovered that HPV associated OAC had a distinct distribution of molecular aberrations/genomic abnormalities compared with HPV negative OAC indicating different biological mechanisms of tumor formation. 8 HPV-positive OAC harbored 50% less nonsilent somatic mutations than HPV-negative oesophageal cancers. Again, we found TP53 aberrations were absent in the HPVpositive OAC group whereas 50% of the HPV-negative OAC patients exhibited TP53 mutations. Furthermore, HPV negative cancers were enriched with cancer driver gene mutations, but not HPV-positive tumors. Viral integration analysis identified hybrid sequences containing HPV16 and the human genome providing evidence for a host-viral interaction. 8 Nevertheless, prior negative studies using PCR techniques exist due to poor tissue classification, suboptimal testing methodology compounded by low viral load, racial and geographic variations. [9] [10] [11] Almost, all these retrospective investigations used paraffin embedded tissue instead of fresh frozen material, which in our experience will yield a false negative PCR DNA result for hr-HPV in 60% of cases. 4 Moreover, we have previously noted that 39% of HPV DNA and E6/E7 mRNA positive BD and OAC lesions did not exhibit increased p16
INK4A expression. Conversely, 16% of lesions negative for both HPV DNA and E6/E7 mRNA showed p16 INK4A overexpression. 2 Although p16 INK4A positive staining is considered a good surrogate marker of HPV biological viral activity, it is not specific for HR-HPV. 2, 12, 13 E6/E7 mRNA analysis by RT PCR in fresh frozen specimens require large quantity of tissue and is technically demanding.
Thus, to circumvent some of the above shortcomings, we sought to identify other biomarkers of active HPV infection, which could be performed quickly and inexpensively on formalin-fixed paraffin embedded (FFPE) biopsies when fresh frozen samples are not readily available. To this end, we were keen to investigate by way of immune-histochemistry (IHC), the major proteins in the regulatory pathway controlled by the retinoblastoma protein (pRb), that is, pRb itself, p16 INK4A , cyclin D 1 , and additionally, p53. pRb is degraded by viral E7 oncoprotein 14 with consequent downregulation of pRb, cyclin D 1 and upregulation of p16 INK4A in head and neck squamous cell carcinoma (HNSCC), another malignancy in which a subset of lesions are HPV driven. 15, 16 P53 is inactivated by the HPV E6 oncoprotein with reduced or loss of staining on IHC. 17 Unfortunately, there are conflicting reports on the use of Cyclin D1 as a marker for HPV-driven tumors. 18, 19 Therefore, we hypothesized that BD and OAC with biologically active HPV (DNA 1 & E6/E7mRNA1) would exhibit overexpression of p16 INK4A and reduced/absent pRb and Cyclin D1 . Furthermore, p53 IHC expression would be low, that is, absent/normal. Hence, we prospectively studied the IHC staining of the above major cellular proteins and the tumor suppressor gene, p53 in relation to biological activity of HPV [DNA PCR of fresh frozen tissue including viral load, E6/E7 mRNA in-situ hybridization (ISH) using FFPE] of OAC and its precursor lesions, BD and BO. In addition, NGS was performed on fresh frozen tissue to determine if reduced or absent p53 staining was indeed wild-type TP53.
Material and Methods

Study design
A prospective cross-sectional method was used to estimate the prevalence of HPV virus and cellular protein markers in fresh frozen and FFPE biopsy samples of patients representing the BM-dysplasia-adenocarcinoma sequence.This was performed in a cohort of Australian Caucasian patients undergoing gastroscopy in a regional hospital (Launceston General Hospital, Launceston, Tasmania) and a tertiary referral centre (Bankstown-Lidcombe Hospital, Sydney, New South Wales) between July 2008 and March 2016. Ethical approval was obtained from the Human Research Ethics Committee, Tasmania (H9304) and South Western Sydney Local Health Network (HREC/11/ LPOOL/42, LNR/12/LPOOL/221, LNR/12/LPOOL/131).
Patient selection and biopsy protocol
Following written consent prior to endoscopy, age, gender, weight and height, smoking (ever smoked), alcohol histories and medications (statins, nonsteroidal anti-inflammatory drugs (NSAID's)/aspirin and proton pump inhibitors) were recorded. Patients who had used NSAID's/aspirin for at least 3 days at any dosage within 3 months prior to the index endoscopy were considered to be NSAID/aspirin users. 20 Excess alcohol consumption was defined as >21 units per week for men and >14 units for women. 21 Inclusion criteria. All patients aged 18-90 undergoing evaluation/surveillance/ablation of endoscopically and histologically proven BM/BD/OAC. 
Specimen collection
Chromoendoscopy assisted targeted biopsies were obtained from the SCJ (n 5 2) and from within the Barrett's columnar/dysplastic/adenocarcinoma segment (n 5 2) using separate forceps for each of the biopsies. A single fresh biopsy specimen from each of the two locations was placed on dry ice and transported to the laboratory for DNA isolation and the other tissue biopsy was formalin fixed for IHC. In addition, fresh frozen and FFPE tumor specimens obtained surgically from 17 patients were also included in this study.
Laboratory studies
DNA isolation, PCR, viral genotyping and viral load detection
Genomic DNA was extracted using QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) as per the manufacturer's instructions. The quantity and quality of genomic DNA was determined by Nanophotometer (Implen, Munchen, Germany). Amplification of human beta-globin was performed to assess sample quality and adequacy. The presence of HPV genome was tested by nested PCR amplifying a conserved HPV L1 gene using MY09/MY11 consensus (general) primers for external, and GP51/61 for internal PCR. 22 To minimize PCR contamination, separate rooms were used for reaction preparation, template handling, performing nested reactions and post PCR analysis. Routine decontamination by UV-irradiation was performed in the DNA-free PCR hood before each run. To guard against systematic contamination of PCR reagent, proper positive and negative controls were included in each step of the PCR process. PCR was run thrice to confirm result reproducibility. PCR products were purified by QIAquick PCR Purification Kit followed by Sanger sequencing. Sequencing results were compared with the documented virus sequences available in the GeneBank database using the BLAST algorithm (http:// blast.ncbi.nlm.nih.gov/). Real Time-PCR (RT-PCR) assays measuring HPV E6/E7 copy number were performed to determine viral load.
3 Viral load was defined as measuring the abundance of a HPV genomic fragment by PCR, and from which the genome copy number was estimated. HPV viral loads in each specimen were expressed as the median number of HPV E6 gene copies per thousand cells. All qPCR reactions were run in duplicate and only high concordance results from duplicate samples were averaged for analysis. E6H4, mtm laboratories and Heidelberg, Germany), respectively. For cyclin D1, p53 and pRb, antigen retrieval was carried out using high pH target retrieval solution for 20 min on a 988C water bath. After cooling, endogenous peroxidase was blocked by peroxidase-blocking reagent; section were then incubated with primary antibodies; cyclin D1 (1:100; Clone EP12, Dako), p53 (1:100 clone DO7, Dako) and pRb (1:100; Pharmingen), for 20 min at room temperature, washed with 13 wash buffer, treated with EnVision FLEX1 horse radish peroxidase visualization system and counterstained with hematoxylin. The p16 INK4A staining was performed according to the manufacturers' instructions. Negative control was included by substitution of primary and secondary antibodies with human serum. A tissue section of cancer known to be positive for the particular protein marker studied was included in each run. Normal oesophageal squamous tissue from a lesion-free patient was used as a staining reference for all four cellular protein markers. All slides were independently examined by two experienced gastrointestinal pathologists blinded to the clinical information. For ease of evaluation, only two categories of staining were applied to all the biomarkers, that is, high or low expression. Cyclin D1 and pRb nuclear staining of at least moderate intensity in a minimum of 25% of the oesophageal lesional cells was considered high expression. In the case of p53, intense nuclear staining of >10% of oesophageal cells was considered as over-expression. 4 For p16 INK4A , at least moderate intensity staining of both nucleus and
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cytoplasm in >25% of oesophageal tissue was considered as p16 overexpression (p16 high ). Staining of any biomarker <25% was deemed low expression. Where there was a discrepancy in scoring, the slides were reviewed together by both pathologists and a mutually agreed final score recorded. Sequencing Kit (Life Technologies) was used for sequencing reactions, as per the recommended protocol. Sequencing data was initially processed by the Torrent Suite v4.2 (Ion Torrent platform-specific pipeline software). Variant Caller plugin included in Torrent Suite Software (v.4.6.0.7; Life Technologies) was used to identify variations in the P53 gene. To exclude erroneous base calling, the filter was set at an average total coverage depth >100, each variant coverage >20, variant frequency of each sample >5, and p values < 0.01. The mutations were further visually examined using Integrative Genomics Viewer software to filter out possible strand-specific errors. Finally, the sequencing mutations were compared with p53 coding sequence available at the IARC TP53 database (http://p53.iarc.fr).
Statistical analysis
Associations between HPV status and clinical characteristics were assessed using a two sample t test Table S1 ). The predominant genotypes were the high risk strains, that is, HPV 16 (n 5 42) and 18 (n 5 13) and a single patient had the low-risk genotype 6 (n 5 1). No multiple genotypes were detected. Assessment for HPV E6/E7 mRNA using RNAScope revealed that 93% of slides stained by the positive control probe (UBC) were positive for host mRNA gene expression. None of the specimens showed positive signals for bacterial gene dapB. All patients with transcriptionally active HPV, that is, DNA positive and E6/E7 mRNA positive were found in the dysplastic and adenocarcinoma Group (4 LGD, 7 HGD, 10 OAC). No E6/E7 mRNA signals were detected in adjacent squamous tissue (Fig. 1) Figure S1 ).
Prevalence of cellular protein markers in oesophageal lesions
Oesophageal squamous mucosa at the SCJ revealed absent or low expression of p16 INK4A , pRb, cyclin D1 and p53 (Fig. 2) . Fig. 2 ). This is in contrast to HPV DNA -and RNA (Table 3) . Nevertheless, p16
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INK4A high had the best balance of sensitivity (66.7%) and specificity (69%) for a single molecular marker though the OR was much less at 6.5 (95% CI 5 2.1-19.9, p 5 0.001). Table S2 ], we reanalyzed the transcriptionally active HPV cohort against the viral negative patients for the same protein markers and combinations (Table 4 ). The data clearly demonstrates a stronger positive association for almost all of the single cellular markers and their combinations. Of note, the strength of associations of p53 low , p16 high /pRb low , p16 high /p53 low , p16 high /pRb low /p53 low , p16 high /cyclin D1 low /p53 low and p16 high /pRb low /cyclin D1 low / p53 low with BD/OAC containing biologically active virus was greatly exaggerated. Nevertheless, sensitivity and specificity were generally similar.
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) P16
Next generation sequencing of TP53
Sequencing was mainly targeted at the dysplastic and adenocarcinoma lesions as all biologically active virus was contained herein. Amongst 137 BD/OAC specimens subjected to p53 gene sequencing, successful analysis was achieved in 112 samples. Twenty-five specimens were excluded from analysis due to unsatisfactory DNA quality/quantity or poor sequence coverage.
Amongst the 112 BD/OAC analysed, 65 (58%) had wildtype TP53 and 47 (42%) harboured mutations. In the 47 specimens with TP53 mutations, 37 (79%) were missense mutations present in the DNA binding domain (exons 5-8; aa102-292), another three (6%) were missense mutations in the oligomerisation domain (exons 9-10) and one was a frameshift mutation in exon 8 which induced a loss of both DNA binding and oligomerisation domains. Interestingly, in the 17 specimens positive for both HPV DNA and RNA, TP53 mutations were detected in only one sample (1/17, 5.9%) and this matched the IHC data (100% concordance). In contrast, TP53 mutations were much commoner in the viral negative and HPV DNA For completeness sake, we also sequenced 16 BM samples (2 had p53 high and the remainder 14 showed absent/low or normal expression on IHC). In this nondysplastic group, there was 94% (15/16) correlation between nucleotide sequencing results and p53 IHC data. The only discrepancy was a wild-type status detected in one of the p53 high specimens.
Thus, overall, 128 BM/BD/OAC samples were sequenced for the TP53 gene and the analysis was concordant with p53 IHC data in 80.5% of cases.
Discussion
In this study, we have identified biomarkers of active HPV infection in BD and OAC, which could be performed quickly and inexpensively on FFPE biopsies when fresh frozen samples are not readily available. Our data confirms that upregulation of p16 INK4A , downregulation of pRb and reduced/ normal/absent p53 are highly characteristic of BD/OAC with transcriptionally active hr-HPV, just as in HNSCC 24 and cervical malignancy. 25 In particular, p53 low showed the strongest association with the DNA 4, 8 P16 high was also strongly associated with biologically active HPV in BD/OAC with a reasonable sensitivity and specificity. This data supports the conventional wisdom of defining biological activity of HPV in BD as E6/E7 mRNA 
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Rajendra et al. current investigation was 48.8% using RNAscope in FFPE samples, which was almost identical to the the 48% detection rate of E6/E7 mRNA transcripts using RT-PCR in fresh frozen tissue of DNA 1 BD/EAC in another study of ours. 2 To reduce the risk of DNA/RNA invalidity, all biopsy tissue was analysed within 5 years of collection. Great care was undertaken to minimize cross-contamination of samples and thus avoid false positive HPV DNA detection. Moreover, only transcriptionally active HPV was considered relevant as detection of viral DNA alone is insufficient to identify HPVdriven cancers. 2, 34 No viral biological activity was detected in adjacent squamous epithelium. Central reporting of slides was performed by academic gastrointestinal pathologists.
Limitations of this investigation
The hybrid nature of the study population may limit the accuracy of the prevalence rates for HPV. Multiple biopsies from the dysplastic/carcinoma segment was unavailable to assess for circumferential and longitudinal discordance for viral and protein marker detection. Microdissection of tissue specimens may have increased the yield of lesional cells for analysis. IHC analysis is subjective and compounded by the lack of uniform scoring systems, which hampers reproducibility between studies.
In conclusion, we have clearly shown that BD/OAC with active HPV involvement is characterized at the molecular level by wild-type p53 and aberrations of the retinoblastoma protein pathway. We should exploit this data for diagnostic, disease stratification, surveillance and treatment (including vaccination) purposes, just as in HNSCC and cervical cancer. The HPV DNA 1 /RNA -oesophageal lesions warrant further study so as to distinguish between a biologically irrelevant (passenger) infection from a true virally driven disease state.
